Q2 2025 Siemens Healthineers AG Earnings Call Transcript
Key Points
- Siemens Healthineers AG (SMMNY) reported a nearly 7% growth in Q2, surpassing the pace guided for the full year.
- The company achieved a strong equipment book-to-bill ratio of 1.14, indicating robust demand.
- Imaging segment grew by close to 9% with a significant margin uplift to 22.4%.
- Free cash flow increased by 64% year-over-year, reaching EUR1 billion for the first half of fiscal year 2025.
- Siemens Healthineers AG (SMMNY) entered into its largest ever value partnership worth CAD800 million with the provincial government of Alberta, Canada, enhancing its position in cancer care.
- The company had to lower the bottom end of its EPS outlook range due to new tariffs and a rapidly changing global trade environment.
- Varian's margin was temporarily held back by a high equipment share in revenue, impacting profitability.
- The Diagnostics segment faced challenges with volume-based procurement impacting top and bottom lines.
- The geopolitical and macroeconomic context, including tariffs, poses risks and uncertainties for future performance.
- China's market remains on lower levels due to anticorruption campaigns, affecting investment decisions and demand.
Good morning, ladies and gentlemen, and welcome to Siemens Healthineers Conference Call. As a reminder, this conference is being recorded. Before we begin, I would like to draw your attention to the safe harbor statement on page 2 of the Siemens Healthineers presentation. This conference call may include forward-looking statements. These statements are based on the company's current expectations and certain assumptions and are, therefore, subject to certain risks and uncertainties.
At this time, I would like to turn the call over to your host today, Mr. Marc Koebernick, Head of Investor Relations. Please go ahead, sir.
Thank you, operator. Good morning, and welcome to our Q2 2025 earnings call. It's great that you're listening again today. 7:00 AM, we published our Q2 2025 results. All the related material for today's results release is available on the IR section of the Siemens Healthineers web page.
In a moment, our CEO, Bernd Montag; and our CFO, Jochen Schmitz, will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
